NCT06336707View on ClinicalTrials.gov

HS-20089 Combination Treatment in Subjects With Advanced Solid Tumors

PHASE1RecruitingINTERVENTIONAL
Enrollment

1,048

Participants

Timeline

Start Date

April 11, 2024

Primary Completion Date

April 8, 2026

Study Completion Date

April 8, 2028

Conditions
Advanced Solid Tumors
Interventions
DRUG

HS-20089

Intravenous infusion

DRUG

Adebrelimab

Intravenous infusion

DRUG

Bevacizumab

Intravenous infusion

DRUG

Cisplatin / carboplatin

Intravenous infusion

Trial Locations (1)

430000

RECRUITING

Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology, Shanghai

All Listed Sponsors
lead

Hansoh BioMedical R&D Company

INDUSTRY